Given the abundance of literature highlighting the role of NTRK2 in cancer, we found similar whole gene NTRK2 expression across Normal Brain, LGG and GBM samples, suggesting that differences in expression of particular splice variants may underlie potential oncogenic effects driven by NTRK2 (Table 2, Supplementary Data 1). The gene discussed is NTRK2; the disease is cancer.